Epidemiological Profile of Patients Hospitalized with Crohn's Disease Due to Severe Acute Respiratory Infection During the COVID-19 Pandemic: a 2-year Report from Brazil

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Nov 7

PMID 39507710

Authors

Lais Silva Nascimento

Fernando Augusto Lima Marson

Raquel de Cassia Dos Santos

Affiliations

Soon will be listed here.

Abstract

Background And Aims: The novel coronavirus-induced severe acute respiratory syndrome (COVID-19) led to one of the most significant global pandemics of the 21st century, causing substantial challenges for healthcare systems worldwide, including those in Brazil. This study aimed to investigate the demographic and clinical profiles of hospitalized patients in Brazil who had both COVID-19 and Crohn's disease (CD) over a 2-year period.

Methods: An epidemiological analysis was conducted using data from Open-Data-SUS. The study focused on describing the demographic characteristics, clinical manifestations, comorbidities, and hospitalization details of patients afflicted with severe acute respiratory syndrome due to COVID-19 and CD, with the aim of predicting mortality risk.

Results: The states of São Paulo, Paraná, and Minas Gerais accounted for 50% of the reported COVID-19 cases. The most affected racial group consisted of individuals who self-declared as mixed race. Common comorbidities included heart disease, diabetes mellitus, and obesity. The age group most affected was 25 to 60 years old, particularly among hospitalized patients with both CD and COVID-19 who ultimately succumbed to the illness. A multivariable analysis was conducted to identify the following significant risk factors for death: (a) the presence of neurological disorder (OR = 6.716; 95% CI = 1.954-23.078), (b) the need for intensive care (OR = 3.348; 95% CI = 1.770-6.335), and (c) the need for invasive mechanical ventilation (OR = 59.017; 95% CI = 19.796-175.944).

Conclusion: There was no discernible gender-based prevalence among hospitalized patients with CD and COVID-19; however, individuals of mixed race were disproportionately affected. The 25 to 60 age group emerged as the most vulnerable demographic group, with high risks of hospitalization and mortality. Moreover, the study highlights the potential for COVID-19 to induce systemic pathologies that may result in long-term degenerative effects and sequelae.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Tepasse P, Vollenberg R, Nowacki T . Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?. Life (Basel). 2021; 11(11). PMC: 8620225. DOI: 10.3390/life11111220. View

Ge L, Liu S, Li S, Yang J, Hu G, Xu C . Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut-brain communications. Front Immunol. 2022; 13:1016578. PMC: 9583867. DOI: 10.3389/fimmu.2022.1016578. View

Baqui P, Bica I, Marra V, Ercole A, van der Schaar M . Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020; 8(8):e1018-e1026. PMC: 7332269. DOI: 10.1016/S2214-109X(20)30285-0. View

Sansone N, Boschiero M, Ortega M, Ribeiro I, Peixoto A, Mendes R . Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic. Lancet Reg Health Am. 2022; 8:100177. PMC: 8739500. DOI: 10.1016/j.lana.2021.100177. View

Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y . COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther. 2020; 5(1):256. PMC: 7605138. DOI: 10.1038/s41392-020-00373-7. View

Sansone N, Boschiero M, Darrieux M, Marson F . Effectiveness of influenza vaccination against coronavirus disease (COVID)-19 outcomes in hospitalized individuals in Brazil: an epidemiological study. Public Health. 2023; 225:8-11. DOI: 10.1016/j.puhe.2023.09.015. View

Belei O, Basaca D, Olariu L, Pantea M, Bozgan D, Nanu A . The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients. J Clin Med. 2024; 13(5). PMC: 10932475. DOI: 10.3390/jcm13051361. View

Luber R, Duff A, Pavlidis P, Honap S, Meade S, Ray S . Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study. JGH Open. 2022; 6(1):76-84. PMC: 8762622. DOI: 10.1002/jgh3.12699. View

10.

Ranzani O, Bastos L, Gelli J, Marchesi J, Baiao F, Hamacher S . Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021; 9(4):407-418. PMC: 7834889. DOI: 10.1016/S2213-2600(20)30560-9. View

11.

Su W, Lu K, Chan C, Chao Y . COVID-19 and the lungs: A review. J Infect Public Health. 2021; 14(11):1708-1714. PMC: 8486577. DOI: 10.1016/j.jiph.2021.09.024. View

12.

Sansone N, Boschiero M, Marson F . Epidemiologic Profile of Severe Acute Respiratory Infection in Brazil During the COVID-19 Pandemic: An Epidemiological Study. Front Microbiol. 2022; 13:911036. PMC: 9288583. DOI: 10.3389/fmicb.2022.911036. View

13.

Sanche S, Lin Y, Xu C, Romero-Severson E, Hengartner N, Ke R . High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020; 26(7):1470-1477. PMC: 7323562. DOI: 10.3201/eid2607.200282. View

14.

Palamim C, Siqueira B, Boschiero M, Marson F . Increase in COVID-19 underreporting among 3,282,337 Brazilian hospitalized patients due to SARS: A 3-year report and a major concern for health authorities. Travel Med Infect Dis. 2023; 54:102616. DOI: 10.1016/j.tmaid.2023.102616. View

15.

Hillesheim D, Tomasi Y, Figueiro T, de Paiva K . Severe Acute Respiratory Syndrome due to COVID-19 among children and adolescents in Brazil: profile of deaths and hospital lethality as at Epidemiological Week 38, 2020. Epidemiol Serv Saude. 2020; 29(5):e2020644. DOI: 10.1590/S1679-49742020000500021. View

16.

Boschiero M, Palamim C, Ortega M, Marson F . Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil. Hum Genet. 2022; 141(12):1887-1904. PMC: 9244024. DOI: 10.1007/s00439-022-02468-3. View

17.

Sze S, Pan D, Nevill C, Gray L, Martin C, Nazareth J . Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2020; 29:100630. PMC: 7658622. DOI: 10.1016/j.eclinm.2020.100630. View

18.

Le Berre C, Honap S, Peyrin-Biroulet L . Ulcerative colitis. Lancet. 2023; 402(10401):571-584. DOI: 10.1016/S0140-6736(23)00966-2. View

19.

Pai R, Geboes K . Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?. Virchows Arch. 2017; 472(1):99-110. DOI: 10.1007/s00428-017-2156-5. View

20.

Rubin G, Biviano A, Dizon J, Yarmohammadi H, Ehlert F, Saluja D . Performance of electrophysiology procedures at an academic medical center amidst the 2020 coronavirus (COVID-19) pandemic. J Cardiovasc Electrophysiol. 2020; 31(6):1249-1254. PMC: 7262273. DOI: 10.1111/jce.14493. View